ABT-263, 25 mg

ABT-263, 25 mg — Small-molecule BCL-2/BCL-xL inhibitor (navitoclax) used to induce apoptosis in preclinical cell-based studies. Supplied by STEMCELL Technologies. Typically dissolved in DMSO; store at -20°C and minimize freeze/thaw cycles. Use appropriate safety precautions; for research use only, not for clinical or diagnostic applications.